News

Tissue Regenix Group Expects Positive First-Half Earnings

1 Mins read

London, UK – Tissue Regenix Group, a leading medical-devices company, has announced that it is on track to meet its targets for 2023. The company anticipates that its adjusted earnings for the first half of the year will be positive following a significant increase in revenue.

With revenue estimated at approximately $14.1 million for the six months ending June 30, Tissue Regenix Group has achieved a record high and a notable 19% year-on-year growth.

Moreover, the company expects to report positive adjusted earnings before interest, taxes, depreciation, and amortization (Ebitda) for the period. This follows their achievement of adjusted Ebitda profitability in the final quarter of 2022.

“We are optimistic about our future prospects and remain committed to our growth objectives,” stated Chief Executive Daniel Lee confidently. Adding further assurance, he emphasized that the company has ample financial resources to support its plans.

Tissue Regenix Group’s anticipated success in the first half of the year sets a positive trajectory for the remainder of 2023 and beyond.

Related posts
News

Sberbank's CEO not keen on Russia's digital ruble - 'I don't see its advantages'

2 Mins read
Over 130 countries are exploring digital currencies in response to declining cash usage and competition from cryptocurrencies like Bitcoin. German Gref, CEO…
News

Newsroom Panama

1 Mins read
Panama President Mulino Supports Jorge Herrera’s Election and Reiterates Respect for the Separation of Powers Cryptocurrency Holders: How to Earn Daily Income…
News

$69.5 Million Bitcoin ETF Holder Files for IPO

2 Mins read
Software manufacturer Figma has registered for an initial public offering (IPO) and announced that it holds $69.5 million in a Bitcoin exchange-traded…

Leave a Reply

Your email address will not be published. Required fields are marked *